CVE:MNXManitex Capital Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Manitex Capital Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add C$0.29 -0.01 (-1.69 %) (As of 06/3/2020 04:00 PM ET) Add Compare Share Today's RangeC$0.29Now: C$0.29▼C$0.3050-Day RangeC$0.14MA: C$0.23▼C$0.2552-Week RangeC$0.15Now: C$0.29▼C$0.30Volume30,500 shsAverage Volume15,292 shsMarket CapitalizationC$3.64 millionP/E Ratio0.38Dividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsInsider TradesHeadlinesSocial Media Manitex Capital Inc., through its subsidiary, Valeo Pharma Inc., acquires and markets specialty pharmaceutical products, and distributes third-party pharmaceutical products primarily in Canada. It operates through two segments, Investments and Pharmaceutical. The company sells its products through wholesalers and retail pharmacy chains, as well as through hospitals and other groups. It also invests in marketable securities, as well as provides consulting services for private companies. Manitex Capital Inc. is headquartered in Kirkland, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Manitex Capital. Previous Next 2.6 Community Rank Outperform VotesManitex Capital has received 12 “outperform” votes. (Add your “outperform” vote.)Underperform VotesManitex Capital has received 11 “underperform” votes. (Add your “underperform” vote.)Community SentimentManitex Capital has received 52.17% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Manitex Capital and other stocks. Vote “Outperform” if you believe MNX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MNX will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldManitex Capital does not currently pay a dividend.Dividend GrowthManitex Capital does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Manitex Capital insiders have not sold or bought any company stock. Previous Next 1.9 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Manitex Capital is 0.38, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 16.10.Price to Earnings Ratio vs. SectorThe P/E ratio of Manitex Capital is 0.38, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.39.Price to Book Value per Share RatioManitex Capital has a P/B Ratio of 0.22. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.90 out of 5 stars Industry, Sector and Symbol Stock Exchange CVE Industry Medical Distribution Sub-IndustryN/A SectorMedical Current SymbolCVE:MNX Previous Symbol CUSIPN/A CIKN/A WebN/A Phone514-693-8844Debt Debt-to-Equity Ratio1.54 Current Ratio5.74 Quick Ratio4.72Price-To-Earnings Trailing P/E Ratio0.38 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesC$4.38 million Price / Sales0.83 Cash FlowC$0.29 per share Price / Cash Flow1.00 Book ValueC$1.29 per share Price / Book0.22Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares12,561,000Market CapC$3.64 million Next Earnings DateN/A OptionableNot Optionable TSXV:MNX Rates by TradingView Receive MNX News and Ratings via Email Sign-up to receive the latest news and ratings for MNX and its competitors with MarketBeat's FREE daily newsletter. Manitex Capital (CVE:MNX) Frequently Asked Questions Has Manitex Capital been receiving favorable news coverage? News stories about MNX stock have trended somewhat positive recently, InfoTrie reports. The research group identifies negative and positive media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Manitex Capital earned a media sentiment score of 0.9 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutManitex Capital. Who are some of Manitex Capital's key competitors? Some companies that are related to Manitex Capital include EBOS Group (EBO), Udg Healthcare (UDG), TSE:AND (AND), Paragon Care (PGC), KDA Group (KDA), Anhui Conch Cement (SHTDY), MCKESSON EUROPE/ADR (CAKFY) and Synergy CHC (SNYR). View all competitors. Who are Manitex Capital's key executives? Manitex Capital's management team includes the following people: Mr. Steven Saviuk, Chairman, Pres & CEO (Age 60)Ms. Helen Saviuk, CFO & DirectorMr. Ronald S. Perry CA, CPA, Sec. & Independent Director (Age 63)Mr. Marc Leger, Exec. VP of Commercial Operations - Valeo Pharma IncNathalie Therrien, Vice-Pres of QA & Regulatory Affairs - Valeo Pharma Inc. What is Manitex Capital's stock symbol? Manitex Capital trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MNX." How do I buy shares of Manitex Capital? Shares of MNX and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab. What is Manitex Capital's stock price today? One share of MNX stock can currently be purchased for approximately C$0.29. How big of a company is Manitex Capital? Manitex Capital has a market capitalization of C$3.64 million and generates C$4.38 million in revenue each year. How can I contact Manitex Capital? The company can be reached via phone at 514-693-8844. This page was last updated on 6/3/2020 by MarketBeat.com Staff
